Emerging role of long non-coding RNAs in cancer precision medicine

Aritro Nath; R. Stephanie Huang

doi:10.1080/23723556.2019.1684130

Emerging role of long non-coding RNAs in cancer precision medicine

Aritro Nath, R. Stephanie Huang

Experimental and Clinical Pharmacology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.

Original language	English (US)
Article number	1684130
Journal	Molecular and Cellular Oncology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1080/23723556.2019.1684130
State	Published - Jan 2 2020

Bibliographical note

Funding Information:
This work was supported by the National Cancer Institute [R01CA204856].

Publisher Copyright:
© 2019, © 2019 Taylor & Francis Group, LLC.

Keywords

Long non-coding RNA
drug response prediction
pharmacogenomics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1080/23723556.2019.1684130

Find It

Find It at U of M Libraries

Cite this

@article{70d17a3578ea461d92cc34f3163cb710,

title = "Emerging role of long non-coding RNAs in cancer precision medicine",

abstract = "A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.",

keywords = "Long non-coding RNA, drug response prediction, pharmacogenomics",

author = "Aritro Nath and Huang, {R. Stephanie}",

note = "Funding Information: This work was supported by the National Cancer Institute [R01CA204856]. Publisher Copyright: {\textcopyright} 2019, {\textcopyright} 2019 Taylor & Francis Group, LLC.",

year = "2020",

month = jan,

day = "2",

doi = "10.1080/23723556.2019.1684130",

language = "English (US)",

volume = "7",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - Emerging role of long non-coding RNAs in cancer precision medicine

AU - Nath, Aritro

AU - Huang, R. Stephanie

PY - 2020/1/2

Y1 - 2020/1/2

N2 - A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.

AB - A vast majority of the human genome encodes long non-coding RNAs (lncRNAs) as compared to protein-coding genes (PCGs). But most efforts to determine biomarkers of anticancer drug response have focused entirely on PCGs. Comprehensive investigation of lncRNAs and drug response demonstrates that lncRNAs are indeed crucial biomarkers of drug response.

KW - Long non-coding RNA

KW - drug response prediction

KW - pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=85075161066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075161066&partnerID=8YFLogxK

U2 - 10.1080/23723556.2019.1684130

DO - 10.1080/23723556.2019.1684130

M3 - Article

C2 - 31993497

AN - SCOPUS:85075161066

SN - 2372-3556

VL - 7

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

IS - 1

M1 - 1684130

ER -

Emerging role of long non-coding RNAs in cancer precision medicine

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this